BALDRY MARK (Chief Commercial Officer) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/2/2023ACC: 0001628280-23-036466
Officer· Chief Commercial Officer
Since Nov 2022
+34.95K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
34.95K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.95K
Price / share
—
Trade value
—
% of position
New position
10/31/2023
0.00→34.95K
Total
Net shares
+34.95K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2023 | A · Award | +34.95K | — | — | New position | 0.00 | 34.95K |
| Total | +34.95K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported